Biotech

All Articles

Sanofi pays $110M upfront for late-stage radioligand treatment

.Sanofi has actually brought in an overdue access to the radioligand party, paying for one hundred t...

F 2G rears $100M for 2nd try to receive brand-new antifungal to market

.After F2G's 1st try to receive a new training class of antifungal to market was actually derailed b...

Moderna targets $1.1 B in R&ampD costs slices, drops 5 programs among productivity tensions

.Moderna has actually vowed to reduce R&ampD costs by $1.1 billion through 2027. The selection to sh...

Sanofi's $80M bank on Key dystrophy drug finishes in stage 3 crash

.Simply four months after Sanofi wager $80 million in beforehand money on Fulcrum Therapies' losmapi...

Oncternal equity sinks 60% surrounded by cutbacks, trial discontinuations

.Cancer business Oncternal Therapeutics is folding all its own medical tests and giving up personnel...

Roche is actually supporting out hopes that its injectable weight problems prospect might inevitably demonstrate 25% weight loss in late-stage test

.Roche is storing out chances that its injectable weight problems possibility could eventually displ...

Novo Nordisk barrages 'remarkable' fat burning lead for dual-acting dental medication in early test

.Novo Nordisk has elevated the cover on a phase 1 trial of its own dental amylin as well as GLP-1 re...

AbbVie takes legal action against BeiGene over blood cancer cells drug secret method

.Merely a couple of quick full weeks after gaining an FDA Fast Track tag for its own investigational...

Lilly provides one-two blow along with second tranche of positive information on weekly blood insulin candidate

.Soon after a good data decrease for Eli Lilly's efsitora alfa, the Indianapolis-based provider is a...

BridgeBio reduces genetics therapy budget as professional data disappoint

.BridgeBio Pharma is lowering its gene therapy budget and pulling back coming from the method after ...